myeloid dendritic cells + plasmacytoid dendritic cells

This refers to a combination of two distinct types of dendritic cells used together, typically in the context of cell therapy or immunotherapy research. Myeloid dendritic cells (mDCs) are professional antigen-presenting cells derived from myeloid precursors, known for their ability to stimulate T-cell responses and bridge innate and adaptive immunity. Plasmacytoid dendritic cells (pDCs) are a rare subset that secrete large amounts of type I interferons in response to viral infections and also play roles in immune regulation, autoimmunity, and cancer microenvironments[1][3][4]. The combination may be explored for therapeutic purposes such as cancer immunotherapy or modulation of immune responses.